n(g),n(g')-dimethyl-l-arginine has been researched along with Auricular Fibrillation in 16 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
| Excerpt | Relevance | Reference |
|---|---|---|
| "We previously performed a trial of intravenous landiolol hydrochloride during and after cardiac surgery (the PASCAL trial) and demonstrated a preventive effect on postoperative atrial fibrillation (AF)." | 9.16 | Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study. ( Hata, M; Hirayama, A; Kunimoto, S; Nakai, T; Sezai, A; Shiono, M; Yoshitake, I, 2012) |
| "The purpose of this study was to determine whether high asymmetric dimethylarginine (ADMA) levels could predict early recurrence of atrial fibrillation (AF) after successful electrical cardioversion (CV)." | 9.13 | Asymmetric dimethylarginine concentration and early recurrence of atrial fibrillation after electrical cardioversion. ( Feng, W; Qu, X; Song, Y; Xia, W; Yu, Y; Zhang, X, 2008) |
| "Elevated plasma levels of asymmetric dimethylarginine (ADMA) have been reported to be associated with endothelial dysfunction, inflammation, and oxidative stress in multiple cardiovascular diseases." | 7.79 | Plasma asymmetric dimethylarginine and adverse events in patients with atrial fibrillation referred for coronary angiogram. ( Chang, SL; Chao, TF; Chen, SA; Hsieh, MH; Hu, YF; Lin, YJ; Lo, LW; Lu, TM; Tsao, HM; Tuan, TC, 2013) |
| "It has been reported that elevation of asymmetric dimethylarginine (ADMA) concentration is involved in atrial fibrillation (AF) process." | 7.77 | Asymmetric dimethylarginine concentration and recurrence of atrial tachyarrythmias after catheter ablation in patients with persistent atrial fibrillation. ( Dechun, Y; Shuqin, S; Wei, F; Xiufen, Q; Yang, L; Yang, Y; Yanwei, Y; Ying, S, 2011) |
| "LAA thrombus was detected in 27 subjects by transesophageal echocardiography." | 5.42 | Asymmetric dimethylarginine predicts left atrial appendage thrombus in patients with non-valvular atrial fibrillation. ( Chi, Y; Duan, T; Rong, Y; Shao, Y; Wang, Y; Xia, W, 2015) |
| "We previously performed a trial of intravenous landiolol hydrochloride during and after cardiac surgery (the PASCAL trial) and demonstrated a preventive effect on postoperative atrial fibrillation (AF)." | 5.16 | Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study. ( Hata, M; Hirayama, A; Kunimoto, S; Nakai, T; Sezai, A; Shiono, M; Yoshitake, I, 2012) |
| "The purpose of this study was to determine whether high asymmetric dimethylarginine (ADMA) levels could predict early recurrence of atrial fibrillation (AF) after successful electrical cardioversion (CV)." | 5.13 | Asymmetric dimethylarginine concentration and early recurrence of atrial fibrillation after electrical cardioversion. ( Feng, W; Qu, X; Song, Y; Xia, W; Yu, Y; Zhang, X, 2008) |
| "Pathways of oxidative stress, nitric oxide bioavailability and L-arginine derivatives are hypothesized to be related to atrial fibrillation (AF)." | 3.83 | ADMA, subclinical changes and atrial fibrillation in the general population. ( Appelbaum, S; Atzler, D; Bauer, C; Blankenberg, S; Böger, RH; Hoffmann, B; Lackner, KJ; Münzel, T; Ojeda, FM; Ramuschkat, M; Schnabel, RB; Schwedhelm, E; Sinning, CR; Wild, PS; Zeller, T, 2016) |
| "Elevated plasma levels of asymmetric dimethylarginine (ADMA) have been reported to be associated with endothelial dysfunction, inflammation, and oxidative stress in multiple cardiovascular diseases." | 3.79 | Plasma asymmetric dimethylarginine and adverse events in patients with atrial fibrillation referred for coronary angiogram. ( Chang, SL; Chao, TF; Chen, SA; Hsieh, MH; Hu, YF; Lin, YJ; Lo, LW; Lu, TM; Tsao, HM; Tuan, TC, 2013) |
| "It has been reported that elevation of asymmetric dimethylarginine (ADMA) concentration is involved in atrial fibrillation (AF) process." | 3.77 | Asymmetric dimethylarginine concentration and recurrence of atrial tachyarrythmias after catheter ablation in patients with persistent atrial fibrillation. ( Dechun, Y; Shuqin, S; Wei, F; Xiufen, Q; Yang, L; Yang, Y; Yanwei, Y; Ying, S, 2011) |
| "LAA thrombus was detected in 27 subjects by transesophageal echocardiography." | 1.42 | Asymmetric dimethylarginine predicts left atrial appendage thrombus in patients with non-valvular atrial fibrillation. ( Chi, Y; Duan, T; Rong, Y; Shao, Y; Wang, Y; Xia, W, 2015) |
| "Patients with AF-recurrence were older, had a higher proportion of hypertension and long-standing persistent AF." | 1.40 | Successful catheter ablation decreases platelet activation and improves endothelial function in patients with atrial fibrillation. ( Alasady, M; Chakrabarty, A; Lau, DH; Lim, HS; Roberts-Thomson, KC; Sanders, P; Schultz, C; Willoughby, SR; Worthley, MI; Young, GD, 2014) |
| "Thirty five patients had persistent atrial fibrillation (AF)≥ 4months." | 1.38 | The impact of rapid atrial pacing on ADMA and endothelial NOS. ( Bode-Böger, SM; Bukowska, A; Dobrev, D; Goette, A; Hammwöhner, M; Lendeckel, U; Martens-Lobenhoffer, J; Medunjanin, S; Ravens, U; Scalera, F; Weinert, S, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 13 (81.25) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Büttner, P | 1 |
| Bahls, M | 1 |
| Böger, RH | 3 |
| Hindricks, G | 1 |
| Thiele, H | 1 |
| Schwedhelm, E | 3 |
| Kornej, J | 1 |
| Chao, TF | 1 |
| Lu, TM | 1 |
| Lin, YJ | 1 |
| Tsao, HM | 1 |
| Chang, SL | 1 |
| Lo, LW | 1 |
| Hu, YF | 1 |
| Tuan, TC | 1 |
| Hsieh, MH | 1 |
| Chen, SA | 1 |
| McEvoy, M | 1 |
| Schofield, P | 1 |
| Smith, W | 1 |
| Agho, K | 1 |
| Mangoni, AA | 1 |
| Soiza, RL | 1 |
| Peel, R | 1 |
| Attia, J | 1 |
| Lim, HS | 2 |
| Willoughby, SR | 2 |
| Schultz, C | 2 |
| Chakrabarty, A | 1 |
| Alasady, M | 2 |
| Lau, DH | 2 |
| Roberts-Thomson, KC | 1 |
| Worthley, MI | 2 |
| Young, GD | 2 |
| Sanders, P | 2 |
| Polovina, MM | 1 |
| Lip, GY | 1 |
| Potpara, TS | 1 |
| Stamboul, K | 1 |
| Lorin, J | 1 |
| Lorgis, L | 1 |
| Guenancia, C | 1 |
| Beer, JC | 1 |
| Touzery, C | 1 |
| Rochette, L | 1 |
| Vergely, C | 1 |
| Cottin, Y | 1 |
| Zeller, M | 1 |
| Xia, W | 2 |
| Wang, Y | 1 |
| Duan, T | 1 |
| Rong, Y | 1 |
| Chi, Y | 1 |
| Shao, Y | 1 |
| Ramuschkat, M | 1 |
| Appelbaum, S | 1 |
| Atzler, D | 2 |
| Zeller, T | 1 |
| Bauer, C | 1 |
| Ojeda, FM | 1 |
| Sinning, CR | 1 |
| Hoffmann, B | 1 |
| Lackner, KJ | 1 |
| Wild, PS | 1 |
| Münzel, T | 1 |
| Blankenberg, S | 1 |
| Schnabel, RB | 2 |
| Maas, R | 1 |
| Wang, N | 1 |
| Yin, X | 1 |
| Larson, MG | 1 |
| Levy, D | 1 |
| Ellinor, PT | 1 |
| Lubitz, SA | 1 |
| McManus, DD | 1 |
| Magnani, JW | 1 |
| Vasan, RS | 1 |
| Benjamin, EJ | 1 |
| Lao, MC | 1 |
| Liu, LJ | 1 |
| Luo, CF | 1 |
| Lu, GH | 1 |
| Zhai, YS | 1 |
| Chen, XL | 1 |
| Gao, XR | 1 |
| Qu, X | 1 |
| Yu, Y | 1 |
| Zhang, X | 1 |
| Feng, W | 1 |
| Song, Y | 1 |
| Goette, A | 1 |
| Hammwöhner, M | 1 |
| Bukowska, A | 1 |
| Scalera, F | 1 |
| Martens-Lobenhoffer, J | 1 |
| Dobrev, D | 1 |
| Ravens, U | 1 |
| Weinert, S | 1 |
| Medunjanin, S | 1 |
| Lendeckel, U | 1 |
| Bode-Böger, SM | 1 |
| Yang, L | 1 |
| Xiufen, Q | 1 |
| Shuqin, S | 1 |
| Yang, Y | 1 |
| Ying, S | 1 |
| Yanwei, Y | 1 |
| Wei, F | 1 |
| Dechun, Y | 1 |
| Sezai, A | 1 |
| Nakai, T | 1 |
| Hata, M | 1 |
| Yoshitake, I | 1 |
| Shiono, M | 1 |
| Kunimoto, S | 1 |
| Hirayama, A | 1 |
| Gan, C | 1 |
| Leong, DP | 1 |
| Brooks, AG | 1 |
| Kistler, PM | 1 |
| Kalman, JM | 1 |
| Cengel, A | 1 |
| Sahinarslan, A | 1 |
| Biberoğlu, G | 1 |
| Hasanoğlu, A | 1 |
| Tavil, Y | 1 |
| Tulmaç, M | 1 |
| Ozdemir, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Correlation Of CoAGulation Biomarkers and Atrial Fibrillation Burden in Patients Post Catheter Ablation: the COAG-AF Pilot Study[NCT04947657] | 20 participants (Anticipated) | Observational | 2021-09-22 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for n(g),n(g')-dimethyl-l-arginine and Auricular Fibrillation
| Article | Year |
|---|---|
Endothelial (dys)function in lone atrial fibrillation.
Topics: Arginine; Atrial Fibrillation; Biomarkers; E-Selectin; Endocardium; Endothelium, Vascular; Humans; P | 2015 |
2 trials available for n(g),n(g')-dimethyl-l-arginine and Auricular Fibrillation
| Article | Year |
|---|---|
Asymmetric dimethylarginine concentration and early recurrence of atrial fibrillation after electrical cardioversion.
Topics: Aged; Arginine; Atrial Fibrillation; Biomarkers; Electric Countershock; Female; Humans; Male; Middle | 2008 |
Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; | 2012 |
13 other studies available for n(g),n(g')-dimethyl-l-arginine and Auricular Fibrillation
| Article | Year |
|---|---|
Arginine derivatives in atrial fibrillation progression phenotypes.
Topics: Aged; Arginine; Atrial Fibrillation; Biomarkers; Cohort Studies; Disease Progression; Female; Homoar | 2020 |
Plasma asymmetric dimethylarginine and adverse events in patients with atrial fibrillation referred for coronary angiogram.
Topics: Aged; Aged, 80 and over; Arginine; Atrial Fibrillation; Cardiovascular Diseases; Coronary Angiograph | 2013 |
Memory impairment is associated with serum methylarginines in older adults.
Topics: Aged; Aged, 80 and over; Arginine; Atrial Fibrillation; Cohort Studies; Diabetes Mellitus; Education | 2014 |
Successful catheter ablation decreases platelet activation and improves endothelial function in patients with atrial fibrillation.
Topics: Aged; Arginine; Atrial Fibrillation; Biomarkers; Catheter Ablation; Electrocardiography; Endothelium | 2014 |
Atrial Fibrillation Is Associated with a Marker of Endothelial Function and Oxidative Stress in Patients with Acute Myocardial Infarction.
Topics: Aged; Aged, 80 and over; Arginine; Atrial Fibrillation; Biomarkers; Chromatography, High Pressure Li | 2015 |
Asymmetric dimethylarginine predicts left atrial appendage thrombus in patients with non-valvular atrial fibrillation.
Topics: Aged; Arginine; Atrial Appendage; Atrial Fibrillation; Female; Humans; Male; Middle Aged; Nitric Oxi | 2015 |
ADMA, subclinical changes and atrial fibrillation in the general population.
Topics: Adult; Aged; Arginine; Atrial Fibrillation; Biomarkers; Chromatography, Liquid; Echocardiography; El | 2016 |
Asymmetric dimethylarginine, related arginine derivatives, and incident atrial fibrillation.
Topics: Aged; Arginine; Atrial Fibrillation; Biomarkers; Cohort Studies; Female; Humans; Incidence; Male; Mi | 2016 |
[Effect of asymmetrical dimethylarginine for predicting pro-thrombotic risk in atrial fibrillation].
Topics: Arginine; Atrial Fibrillation; Cardiovascular Diseases; Heart Atria; Humans; Stereoisomerism; Thromb | 2016 |
The impact of rapid atrial pacing on ADMA and endothelial NOS.
Topics: Aged; Animals; Arginine; Atrial Fibrillation; Calcium-Binding Proteins; Disease Models, Animal; Endo | 2012 |
Asymmetric dimethylarginine concentration and recurrence of atrial tachyarrythmias after catheter ablation in patients with persistent atrial fibrillation.
Topics: Arginine; Atrial Fibrillation; Biomarkers; Body Surface Potential Mapping; Catheter Ablation; Cohort | 2011 |
Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm.
Topics: Aged; Antithrombin III; Arginine; Atrial Fibrillation; Catheter Ablation; CD40 Ligand; Enzyme Inhibi | 2013 |
Asymmetrical dimethylarginine level in atrial fibrillation.
Topics: Acute Disease; Arginine; Atrial Fibrillation; Chromatography, High Pressure Liquid; Chronic Disease; | 2008 |